An EU-funded project to develop a super-resolution microscope platform capable of visualising DNA, mRNA and proteins in living cells could advance regenerative medicine, potentially leading to breakthroughs in replacing or restoring diseased or malfunctioning human cells, tissues or organs.
Graphene, an atomically thin lattice of carbon, has many exceptional properties. An EU-funded project is developing ways to use this unique nanomaterial efficiently in novel optical technologies with potential applications in medical imaging, biosensing, signal processing and computing.
Innovative equipment has been developed to help patients regain control of limbs despite an injury that stops the transmission of signals through the spinal cord. But what if this transmission could actually be re-established? An EU-funded project is working on an innovative implant, but there is still a very long way to go.
An EU-funded project has advanced breast cancer detection to uncover tumours that are difficult to spot and frequently missed by current technology. The technology could help to save lives and avoid unnecessary biopsies.
EU-funded researchers have shown how nanoparticles can deliver drugs directly to the site of an infection. This preclinical research promises more effective treatments and the prospect of bypassing the threat of antimicrobial resistance.
EU-funded researchers are developing a personalised dosing solution for chemotherapy targeting leukaemia using advanced microfluidic chips to meet the precise medical requirements of individual patients.
The incidence of cancer in Europe is increasing but many potential new drug treatments are found to be ineffective when tested on patients. An EU and industry-funded project has investigated new models of tumours to help researchers discover more effective treatments and boost survival rates.
EU-industry funded researchers have worked to identify and characterise signs of cancer, particularly colon cancers, and patients' responses to different types of treatment. The aim is to help doctors choose the best possible treatment for an individual patient's condition, potentially improving and saving lives.
A novel approach to analysing DNA for signs of mutation and disease is leading to highly accurate tests for early-stage cancer, antibiotic resistance and genetic disorders, potentially revolutionising diagnostic medicine and saving lives.
Novel computing tools and advanced algorithms developed by EU-funded researchers are leading to next-generation electroencephalography technologies to help doctors map brain activity and diagnose disorders faster and more accurately.
